(Q35835882)

10 August 2017

Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice (English)

1 reference

10 August 2017

1 reference

Sander I van Leuven

1

1 reference

10 August 2017

Yanice V Mendez-Fernandez

2

1 reference

10 August 2017

Ashley J Wilhelm

3

1 reference

10 August 2017

Nekeithia S Wade

4

1 reference

10 August 2017

Curtis L Gabriel

5

1 reference

10 August 2017

John J Kastelein

6

1 reference

10 August 2017

Erik S Stroes

7

1 reference

10 August 2017

Paul P Tak

8

1 reference

10 August 2017

Amy S Major

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

27 September 2011

1 reference

Annals of the Rheumatic Diseases

10 August 2017

1 reference

10 August 2017

71

1 reference

10 August 2017

3

1 reference

10 August 2017

408-414

1 reference

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

B cell depletion reduces the development of atherosclerosis in mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Mycophenolate mofetil and atherosclerosis: results of animal and human studies.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Mycophenolate mofetil and its mechanisms of action

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Cardiac involvement in systemic rheumatic diseases: An update

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Pathogenic mechanisms in systemic lupus erythematosus.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Systemic lupus erythematosus.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Systemic inflammation as a risk factor for atherothrombosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306213

Polygenic control of susceptibility to murine systemic lupus erythematosus

6 December 2018

1 reference

12 December 2020

Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels

1 reference

12 December 2020

IL-10 regulation of lupus in the NZM2410 murine model

1 reference

12 December 2020

Genetic variation in the interleukin-10 gene promoter in Polish patients with systemic lupus erythematosus

1 reference

12 December 2020

Atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan

1 reference

12 December 2020

Lupus Atherosclerosis Prevention Study (LAPS)

1 reference

12 December 2020

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

12 December 2020

Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus

1 reference

12 December 2020

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

12 December 2020

10.1136/ANNRHEUMDIS-2011-200071

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

21953346

1 reference